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The ability of Escherichia coli to colonize both intestinal and extraintestinal sites is driven by the presence
of specific virulence factors, among which are the autotransporter (AT) proteins. Members of the trimeric AT
adhesin family are important virulence factors for several gram-negative pathogens and mediate adherence to
eukaryotic cells and extracellular matrix (ECM) proteins. In this study, we characterized a new trimeric AT
adhesin (UpaG) from uropathogenic E. coli (UPEC). Molecular analysis of UpaG revealed that it is translo-
cated to the cell surface and adopts a multimeric conformation. We demonstrated that UpaG is able to promote
cell aggregation and biofilm formation on abiotic surfaces in CFT073 and various UPEC strains. In addition,
UpaG expression resulted in the adhesion of CFT073 to human bladder epithelial cells, with specific affinity
to fibronectin and laminin. Prevalence analysis revealed that upaG is strongly associated with E. coli strains
from the B2 and D phylogenetic groups, while deletion of upaG had no significant effect on the ability of CFT073
to colonize the mouse urinary tract. Thus, UpaG is a novel trimeric AT adhesin from E. coli that mediates
aggregation, biofilm formation, and adhesion to various ECM proteins.
Pathogenic bacteria often interact with their host through
surface proteins referred to as adhesins. Two major classes of
adhesins have been described, and both utilize vastly different
mechanisms for their assembly at the cell surface. Fimbrial
adhesins such as the prototypical type 1 fimbriae of Escherichia
coli are composed primarily of a major repeating subunit pro-
tein and often contain minor-subunit proteins (including the
adhesin) at the tip of the organelle. The biogenesis of these
fimbriae is dependent on a highly conserved chaperone-usher
system (20, 29). Nonfimbrial adhesins are a second class of
adherence factors and encompass a diverse range of adhesins
that includes the autotransporter (AT) family of proteins. AT
proteins are particularly unique in that the information re-
quired for receptor recognition and routing and anchorage to
the outer membrane is provided by the protein itself (25).
Recent studies have identified a new group of nonfimbrial
adhesins that have the capacity to form stable trimeric struc-
tures on the bacterial cell surface. These adhesins are charac-
terized by a membrane-anchored C-terminal domain that
forms a trimeric -barrel pore and facilitates the translocation
of a passenger domain (consisting of an extended stalk and an
N-terminal head) to the bacterial cell surface via the type V
secretion pathway (54, 67).
Trimeric AT proteins have been identified from a range of
different gram-negative bacterial pathogens. Where character-
ized, the function of trimeric AT proteins is universally asso-
ciated with bacterial adherence, and thus they constitute an
important group of virulence factors (14). The YadA adhesin
from Yersinia enterocolitica represents the best-characterized
trimeric AT protein. YadA mediates adherence to host epi-
thelial cells and extracellular matrix (ECM) proteins, is crucial
for the colonization of the intestinal mucosa by Yersinia entero-
colitica, and contributes to the serum resistance of Y. entero-
colitica by inhibiting complement activation (3, 24, 68–70). Two
trimeric AT adhesins have been described for Neisseria men-
ingitidis: NadA, which mediates the binding to and invasion of
epithelial cells, and NhhA, which mediates binding to human
epithelial cells and ECM components, such as laminin and
heparan sulfate (12, 59). The BadA protein from Bartonella
henselae is a giant trimeric AT protein of more than 3,000
amino acids that plays a role in binding to ECM proteins and
in cell host infection (52, 53). Hia and Hsf are trimeric AT
proteins from Haemophilus influenzae that have been charac-
terized and that mediate high-affinity adherence to respiratory
epithelial cells (33). Trimeric AT proteins from Moraxella ca-
tarrhalis (UspA1 and UspA2) (27, 34) and plant pathogens
such as Xanthomonas campestris (XadA) (50) have also been
identified.
Escherichia coli is a highly diverse bacterial species that
includes both harmless gut commensal strains and virulent
intestinal and extraintestinal pathogens. In contrast to intesti-
nal pathogens, extraintestinal pathogenic E. coli (ExPEC) can
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inhabit the intestinal tract as part of the normal flora and infect
extraintestinal sites such as the urinary tract, the bloodstream,
and the central nervous system (30). The range of infections
caused by E. coli can be attributed to the extensive variation in
DNA content (up to 1 Mb) that exists between different strain
types. These differences reflect variation in gene content and
are typically associated with pathogenicity islands. For exam-
ple, a genome comparison analysis of the uropathogenic E. coli
(UPEC) strain CFT073 with the E. coli K-12 strain MG1655
showed that they share only 41.7% of their encoded proteins;
14.3% of the proteins encoded by the E. coli K-12 MG1655
genome are absent from E. coli CFT073, while 23.8% of the
proteins encoded by the E. coli CFT073 genome are absent
from E. coli K-12 MG1655 (76). It is therefore reasonable to
assume that part of the CFT073 genome encodes currently
uncharacterized proteins that play a role in virulence.
Previous in silico analysis of the E. coli CFT073 genome
sequence identified the presence of 10 putative proteins po-
tentially secreted via the AT pathway (46). Two of the pre-
dicted proteins are highly homologous to E. coli K-12 antigen
43 (Ag43) protein, Ag43a (c3655), and Ag43b (c1273). We
recently demonstrated that Ag43a and Ag43b possess func-
tional differences; Ag43a promotes strong biofilm growth, and
its expression is associated with long-term persistence in the
urinary bladder (71). The protein encoded by one of the re-
maining putative AT-encoding genes from CFT073 (c4424/
upaG) is highly homologous to members of the surface-ex-
posed trimeric AT adhesins. UpaG was recently identified
through a reverse vaccinology approach as a potentially pro-
tective antigen against ExPEC (17), suggesting the need for
further analysis of its structural and functional properties. In
this study, we performed an in-depth molecular analysis of
UpaG. We have demonstrated that UpaG is exported to the
cell surface by virtue of a C-terminal  domain and that it
mediates the aggregation of E. coli as well as its adhesion to
abiotic surfaces, T24 bladder epithelial cells, and ECM pro-
teins.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The strains and plasmids
used in this study are listed in Table 1. Cells were routinely grown at 37°C in
M63B1–0.2% glucose minimal medium (M63B1glu) unless otherwise specified
and supplemented with the appropriate antibiotic: kanamycin (Km; 50 mg ml1),
chloramphenicol (Cm; 25 mg ml1), ampicillin (Amp; 100 mg ml1), apramycin
(30 mg ml1), or zeocin (50 mg ml1). HeLa epithelial cells (ATCC number
CCL-2), T24 cells (Marinpharm), T24-red epithelial cells (Marinpharm), and
BSC1 cells (ATCC number CCL-26) were maintained in Dulbecco’s modified
Eagle medium (DMEM; Gibco).
DNA manipulations and genetic techniques. DNA techniques were performed
as described by Sambrook et al. (58). Isolation of plasmid DNA was carried out
using the QIAprep Spin Miniprep kit (Qiagen). Restriction endonucleases were
used according to the manufacturer’s specifications (New England Biolabs).
Oligonucleotides were purchased from Sigma (France or Australia) and are
listed in Table S1 in the supplemental material. DNA sequencing was performed
by MWG Services. The construction of mutants and upaG-controlled-expression
strains (PcL and RExBAD) (15, 57) was performed using a three-step PCR
procedure described previously (36; http://www.pasteur.fr/recherche/unites/Ggb
/matmet.html).
Construction of plasmids used in this study. The upaG gene was amplified
from CFT073 by PCR using primers 110 and 139 and ligated into the XhoI site
of pBAD/Myc-HisA to generate plasmid pupaG. Plasmids pUpaGL2-L1-,
pUpaGL1-, and pUpaG were constructed as follows. Plasmid pJun was digested
by BamHI to remove the region encoding the -AT domain of the immunoglobulin
A (IgA) protease from Neisseria gonorrhoeae. The region encoding the translocator
unit of UpaG (including the L2, L1, and  domains) was amplified using primer
BamH-4424-3 in combination with primer BamHTag2.-5, BamHTag2.L1-5, or
BamHTag2.L2-5, respectively. These primers included a sequence encoding the
DPLEPI E-tag epitope. Amplified fragments were cloned into pJun to generate the
plasmids pUpaGL2-L1-, pUpaGL1-, and pUpaG. All plasmid constructs were
verified by sequence analysis and were used to transform E. coli UT5600 for func-
tional expression analysis.
Structural analysis and 3D molecular modeling. The SignalP 3.0 program was
used to predict the signal peptide of UpaG (7), and the SMART program was
used to detect protein domains in UpaG (61). A three-dimensional (3D) model
of UpaG was constructed using the Protein Data Bank files for one outer
membrane translocator domain of the Haemophilus influenzae Hia trimeric AT
protein (Hia shares 20% identity and 30% similarity with UpaG; these percent-
ages increased to 37% identity and 55% similarity when the last 107 amino acids
were compared): 2GR7.pdb (Hia amino acids 992 to 1098) and 2GR8.pdb (Hia
amino acids 1022 to 1098). The structural alignment of the two polypeptide
chains was obtained using the combinatorial extension algorithm (63), which
determines an optimal alignment of multiple protein structures based on a
Monte Carlo optimization method. Multiple-sequence alignment of these pro-
teins with UpaG was performed with Clustal W. The homology model of UpaG
was then generated with the program MODELLER (40). Finally, the SCWRL
3.0 program (11) and energy minimizations were used for protein side chain
conformational predictions. The model generated was subjected to a series of
tests to assess its internal consistency and reliability. Evaluations were performed
using energy criteria and root mean square deviation, Ramachandran plot (in-
spection of / angles), and Procheck programs. The Ramachandran plot sta-
tistics were as follows: for residues in most-favored regions [A,B,L], 94%; for
residues in additional allowed regions [a,b,l,p], 6%; for residues in generously
allowed regions [a,b,l,p], 0%; and for residues in disallowed regions, 0%.
The root mean square deviation calculated using backbone atoms (N, Ca, C, O)
for the Gln9-Gln105 region was 0.83 Å.
Cell aggregation assay. Liquid cultures of E. coli CFT073, CFT073 upaG,
CFT073 PcL upaG, CFT073 RExBAD upaG (supplemented with 0.2% arabi-
nose), and CFT073 RExBAD upaG (supplemented with 0.2% glucose) were
grown separately overnight in M63B1. Cultures were adjusted to an optical
density at 600 nm (OD600) of 2.5 (in 3.0 ml) by dilution with M63B1 medium and
left to stand at room temperature. At regular time intervals, the OD600 of the
upper part of the culture was measured. Cultures of E. coli strains bearing
plasmids pUpaGL2-L1-, pUpaGL1-, and pUpaG were grown separately in
lysogeny broth (LB) to an OD600 of 0.5 and then induced with 1 mM IPTG
(isopropyl--D-thiogalactopyranoside) for 3 h at 37°C under vigorous shaking
conditions. Following this, 100-ml samples were withdrawn at 20-min intervals
from the upper part of the culture and the OD600 was measured. All assays were
performed in triplicate.
Biofilm assays. Biofilm formation on polystyrene surfaces was measured using
96-well microtiter plates (Iwaki) as previously described (57). Briefly, cells were
grown for 24 h in M63B1glu (containing 0.2% arabinose for induction of upaG
gene expression) at 37°C, washed to remove unbound cells, and stained with
0.1% crystal violet. Quantification of bound cells was performed by the addition
of acetone-ethanol (20:80 [vol/vol]) and measurement of the dissolved crystal
violet at an absorbance of 570 nm. All experiments were performed in triplicate.
Generation of anti-UpaG antibodies. A fragment of the upaG gene (encoding
281 amino acids of the passenger domain of UpaG) was amplified using the
primers c4424.943-5 and c4424.1224-3 and cloned into plasmid pET22b to gen-
erate pET22b-F2. The resulting construction was verified by sequencing and
introduced by electroporation into E. coli BL21(DE3). A total of 500 ml of LB
was inoculated with 2 ml of an overnight culture of BL21(pET22b-F2). The cells
were grown to an OD600 value of 0.4 and induced with 1 mM IPTG for 4 h. The
His-tagged UpaG943–1224 protein (a region of UpaG comprising amino acids 943
to 1224 of the N-terminal passenger domain) was purified by affinity chroma-
tography on dry-silica-based resin precharged with Ni2 ions (Protino Ni-TED
resin; Macherey-Nagel). The purity was checked by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Rabbit polyclonal antibodies
were conventionally prepared using purified His-tagged UpaG943–1224. Prior to
immunodetection, the serum was absorbed against a crude protein extract of
CFT073 upaG.
Protein localization and Western blot analysis. Outer membrane extractions
were performed as previously described (16). Briefly, CFT073, CFT073 upaG,
CFT073 PcL upaG, and CFT073 RExBAD upaG (with or without arabinose)
cells were harvested by centrifugation, washed in phosphate-buffered saline
(PBS), and resuspended to an OD600 of 20. The cell suspension was centrifuged,
and the pellet was snap-frozen on dry ice. Cells were then resuspended in
sonication buffer (10% sucrose, 50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 1 mM
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EDTA, 5 mM dithiothreitol, 1 mg ml1 lysozyme) and incubated at 37°C for 10
min and then on ice for 20 min. Complete cell lysis was achieved by sonication,
and cellular debris were removed by centrifugation (10,000 rpm for 5 min). The
supernatant was then incubated with 0.5% Sarkosyl for 30 min at room temper-
ature on a rotating platform. The insoluble outer membrane fraction was har-
vested by centrifugation at 18,000 rpm for 45 min at 4°C, resuspended in 100 ml
of 1	 SDS final sample buffer, and boiled for 3 min prior to gel electrophoresis.
A volume of cells corresponding to an OD600 value of 2.0 was examined by
electrophoresis on an 8% SDS–polyacrylamide gel containing 8 M urea. Immu-
nodetection was performed following transfer onto nitrocellulose membranes
(Protran; Schleicher & Schuell), using a 1:1,000 dilution of polyclonal rabbit
antiserum raised against the UpaG protein.
To monitor the presence of hybrid proteins, a volume of UT5600 cells (con-
taining plasmid pUpaGL2-L1-, pUpaGL1-, or pUpaG) corresponding to an
OD600 value of 2.0 was harvested by centrifugation following induction with 1
mM IPTG. Pellets were resuspended and boiled for 10 min prior to gel electro-
phoresis, and in each case, an amount equivalent to an OD600 value of 2.0 was
loaded onto the gel. Proteins were transferred onto nitrocellulose membranes
(Protran; Schleicher & Schuell), and immunodetection was performed using a
1:10,000 dilution of anti-E-tag monoclonal antibody conjugated with peroxidase
(Amersham Pharmacia).
To determine the levels of fibronectin in T24 and HeLa cells, the cells were
suspended in 250 
l of the lysis buffer (20 mM Tris-HCl, 1% [vol/vol] NP-40, 137
mM NaCl, 5 mM Na3VO4, 30 mM NaF, protease inhibitor cocktail). Cells were
mixed for 15 min at 4°C and pelleted by centrifuged for 15 min. Proteins
contained in the supernatants were examined by SDS-PAGE. Proteins were
transferred onto nitrocellulose membranes (Protran; Schleicher & Schuell), and
immunodetection was performed using a 1:2,000 dilution of antifibronectin an-
tiserum conjugated with peroxidase (Sigma).
Immunofluorescence microscopy. Immunofluorescence microscopy analysis
was performed as follows. Overnight cultures of the different strains were grown
at 37°C in M63B1glu (in the presence of 0.2% arabinose, where indicated below).
Cells were loaded onto 0.1%-poly-L-lysine-treated immunofluorescence micro-
scope slides. Slides were washed three times with PBS. Cells were fixed with 3%
paraformaldehyde for 10 min before being quenched with 50 mM NH4Cl. Slides
were saturated for 15 min with 0.5% bovine serum albumin (BSA) before
incubation with a 1:1,000 dilution of the primary polyclonal rabbit antiserum
raised against UpaG and next with a 1:300 dilution of the secondary polyclonal
goat anti-rabbit serum coupled to Alexa 488 (Molecular Probes-Invitrogen)
along with 10 mg ml1 of 4,6-diamidino-2-phenylindole (DAPI). Finally, the
slides were mounted in Mowiol 4088 (Calbiochem) and observed by epifluores-
cence microscopy with green fluorescent protein and DAPI filters.
TABLE 1. Bacterial strains and plasmids used in this study
E. coli strain(s) or plasmid Relevant characteristic(s) Reference or source
Strains
OS56 MG1655 flu Gfp Ampr 62
OS56(pBAD/Myc-HisA-Kan) OS56 with plasmid pBAD/Myc-HisA-Kan, Kmr 71
OS56(pupaG) OS56 with plasmid pupaG, Kmr This study
CFT073 Wild-type UPEC isolate 42
CFT073 upaG CFT073 upaG::Cm; upaG mutant, Cmr This study
CFT073 PcL upaG CFT073 Km PcL upaG, constitutively expressed upaG, Kmr This study
CFT073 RExBAD upaG CFT073 Cm RExBAD upaG, arabinose-inducible upaG, Cmr This study
UT5600 ompT proC leu-6 trpE38 entA 21
UT5600(pUpaGL2-L1-) UT5600 with plasmid pUpaGL2-L1-, Cm
r This study
UT5600(pUpaGL1-) UT5600 with plasmid pUpaGL1-, Cm
r This study
UT5600(pUpaG) UT5600 with plasmid pUpaG, Cm
r This study
U6 UPEC 73
U15 UPEC 73
E. coli collection 96 commensal E. coli isolates constituted from several animal populations Reference 64 and Table S2
in the supplemental
material
ECOR collection E. coli isolates of different origins 45
UPEC collection UPEC clinical isolates 73
1094 Commensal E. coli isolate from a healthy patient C. Le Bouguenec
1102 Commensal E. coli isolate from a healthy patient C. Le Bouguenec
1103 Commensal E. coli isolate from a healthy patient C. Le Bouguenec
1110 Commensal E. coli isolate from a healthy patient C. Le Bouguenec
1125 Commensal E. coli isolate from a healthy patient C. Le Bouguenec
1127 Commensal E. coli isolate from a healthy patient C. Le Bouguenec
536 UPEC isolate (O6:K15:H31) 8
J96 UPEC isolate (O4:K6) 22
IHE3034 E. coli isolate (O18:K1:H7/9) 32
55989 Enteroaggregative E. coli C. Le Bouguenec
O42 Enteroaggregative E. coli 75
Plasmids
pJun Plasmid with a hybrid outer membrane protein containing the -AT
domain of the IgA protease of N. gonorrhoeae and the leucine zipper
of c-Jun, Cmr
74
pUpaGL2-L1- Plasmid with a hybrid protein containing the leucine zipper of c-Jun and
the L2 and L1 linker and  domains of UpaG of E. coli CFT073, Cmr
This study
pUpaGL1- Plasmid with a hybrid protein containing the leucine zipper of c-Jun and
the L1 linker and  domains of UpaG of E. coli CFT073, Cmr
This study
pUpaG Plasmid with a hybrid protein containing the leucine zipper of c-Jun and
the  domain of UpaG of E. coli CFT073, Cmr
This study
pupaG upaG gene from CFT073 in pBAD/Myc-HisA-Kan, Kmr This study
pET22b-F2 pET22b with 281 amino acids of the N terminus of UpaG (amino acids
943 to 1224), Ampr
This study
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Immunogold electron microscopy. Cells for immunoelectron microscopy were
prepared from overnight cultures of wild-type CFT073, CFT073 upaG, and
CFT073 PcL upaG strains grown at 37°C in M63B1glu. Cells were fixed with
freshly prepared 8% paraformaldehyde at 4°C, embedded in 10% gelatin, and
cryoprotected in 15% polyvinyl pyrrolidone–1.7% sucrose. Blocks were mounted
on aluminum pins and frozen in liquid nitrogen before being cryosectioned with
a cryoultramicrotome (model UC6 FCS; Leica). Thin cryosections (70 nm) were
placed on glow-discharged carbon-coated copper grids, washed twice with PBS,
and quenched with 50 mM NH4Cl before being blocked with 0.5% BSA for 15
min. Samples were reacted with the primary polyclonal rabbit antiserum raised
against UpaG (1:100 dilution in PBS containing 0.5% BSA) for 30 min and
washed four times in PBS (5 min). Samples were then incubated with anti-rabbit
IgG gold conjugate (10-nm diameter, diluted 1:50 in PBS containing 0.5% BSA)
for 30 min and subsequently washed four times (5 min) in PBS followed by four
washes (2 min each) in sterile ultrapure water. Cryosections were embedded in
2% methyl cellulose and stained with 4% uranyl acetate before being examined
under a Jeol JEM1010 transmission electron microscope operated at 80 kV.
Images were captured using an analySIS Megaview III digital camera.
Epithelial cell adhesion assay. The interaction of CFT073, CFT073 upaG,
and CFT073 PcL upaG with cultured T24, HeLa, and BSC1 epithelial cells was
studied essentially as previously described (39). Briefly, wells were seeded with
1.5 	105 cells in six-well tissue culture plates. Once cells were confluent (1.2
	106 cells per well), the culture medium was removed and cells were washed
once with DMEM plus 10% fetal bovine serum. The use of confluent cells
resulted in a reduction in the amount of plastic surface available for bacterial
binding. Overnight bacterial cultures were mixed vigorously by vortexing them in
order to disperse any bacterial cell clumps. Bacteria were added to the mono-
layers at a multiplicity of infection of 10 in DMEM. Incubation was carried out
for 1 h at 37°C in 5% CO2 (longer incubation times resulted in killing of the
eukaryotic cells by CFT073). The inoculating dose of bacteria was confirmed by
serial dilution and plating. The absence of bacterial clumps attached to the
eukaryotic cells was verified with phase-contrast microscopy. Monolayers were
washed three times with DMEM plus 10% fetal bovine serum to remove non-
adherent bacteria. The remaining bacteria were released by eukaryotic cell lysis
with 0.1% Triton X-100. The number of adherent bacteria was determined by
serial dilution and plating. All experiments were performed in triplicate.
Mixed-monolayer cell adhesion assay. T24-red cells expressing the red fluo-
rescent protein and HeLa cells were mixed in different proportions and seeded
on six-well tissue culture plates to obtain a mixed cell culture monolayer. Once
cells were confluent, the proportion of HeLa and T24-red cells was checked by
fluorescence microscopy. Wells with approximately the same proportion of HeLa
and T24-red cells were infected with CFT073 upaG or CFT073 PcL upaG at a
multiplicity of infection of 50. Bacterial cultures were dispersed by vigorous
vortexing prior to infection. After 1 h of incubation at 37°C in 5% CO2, the mixed
cell monolayers were washed with PBS in order to eliminate nonadherent bac-
teria. Cells were fixed with a paraformaldehyde solution (3.5% in PBS) for 15 to
30 min and then permeabilized with 0.1% Triton X-100 for 5 min in PBS. Actin
was labeled by phalloidin Alexa 647 incubated for 30 min at room temperature
in blocking solution, and this permitted the identification of both types of eu-
karyotic cells. Images were acquired on an inverted fluorescence microscope
(Axiovert 135; Carl Zeiss MicroImaging, Inc.) equipped with a cooled, charge-
coupled-device camera (MicroMax, 5 MHz; Princeton Instruments) driven by
Metamorph Imaging System software (Universal Imaging Corp.). Bacteria were
observed by phase-contrast microscopy and were colored green using the Adobe
Photoshop CS program.
Binding assays (enzyme-linked immunosorbent assays [ELISA]). Microtiter
plates (Maxisorb; Nunc) were coated overnight at 4°C with 10 mg of the follow-
ing ECM proteins ml1: heparan (from bovine kidney; Sigma), fibronectin (from
human plasma; Sigma), laminin (from human placenta; Sigma), and human
collagen type I, type III, and type IV (Sigma). BSA (Sigma) was used as a
negative control. Wells were washed twice with TBS (150 mM NaCl, 20 mM Tris,
pH 7.5) and then blocked with TBS–2% milk for 1 h. After being washed with
TBS, 200 
l of CFT073, CFT073 upaG, CFT073 PcL upaG, CFT073 RExBAD
upaG (with arabinose), or CFT073 RExBAD upaG (without arabinose) (OD600 
0.1) was added, and the mixtures were incubated for 2 h. After being washed to
remove nonadherent bacteria, adherent cells were fixed with 4% paraformalde-
hyde, washed a further three times, and incubated for 1 h with anti-E. coli serum
(diluted 1:500 in TBS–Tween 0.5%) and then for 1 h with a secondary anti-rabbit
horseradish peroxidase antibody (diluted 1:1,000). Finally, cells were washed and
adherent bacteria were detected by adding 150 
l of 1-Strep ABTS [2,2-azino-
bis(3-ethylbenzthiazoline-6-sulfonic acid diammonium salt); Pierce] and mea-
surement of absorbance at 405 nm.
Mouse model of UTI. The mouse model of urinary tract infections (UTI)
described previously was used for this study (56). Female C57BL/6 and C3H/HeJ
mice (8 to 10 weeks old) were purchased from the Animal Resources Center,
Western Australia, and housed in sterile cages with ad libitum access to sterile
water. Urine was collected from each mouse 24 h prior to challenge and exam-
ined using a microscope with a hemocytometer and by culture. Mice with a
combination of 5 	 102 CFU of bacteria per ml of urine and 2 	 105 white
blood cells in urine were defined as having a preexisting condition and were
excluded from the study. Mice were anesthetized by brief inhalation exposure to
isoflurane, and the periurethral area was sterilized by swabbing it with 10%
povidone–iodine solution, which was removed with sterile PBS. Mice were cath-
eterized using a sterile Teflon catheter (0.28-mm internal diameter, 0.61-mm
outer diameter, and 25-mm length; Terumo) by inserting the device directly into
the bladder through the urethra. An inoculum of 25 
l, containing 5 	 108 CFU
of bacteria in PBS containing 0.1% India ink was instilled directly into the
bladder using a 1-ml tuberculin syringe attached to the catheter. The catheter
was removed immediately after the challenge, and mice were returned to their
cages. Urine was collected from each mouse at 18 h after inoculation for quan-
titative colony counts. Groups of mice were euthanized at 18 h and 5 days after
challenge by cervical dislocation; bladders were then excised aseptically,
weighed, and homogenized in PBS. Bladder homogenates were serially diluted in
PBS and plated onto LB agar for colony counts. Data are expressed as the mean
total numbers of CFU per 0.1 g of bladder tissue standard errors of the means.
All animal experiments were repeated at least twice with a minimum group size
of eight, and the data shown are the composite of all independent experiments.
RESULTS
Structural analysis of the putative trimeric AT UpaG. The
5,337-bp upaG gene from E. coli CFT073 encodes a protein
that shares many structural features with the trimeric YadA
and NhhA AT proteins. UpaG possesses a characteristically
long putative signal sequence with a predicted cleavage site
after amino acid 53 (Fig. 1A), as well as a large N-terminal
passenger domain (amino acids 54 to 1685) with 14 repeats of
both Hep-Hag and Him motifs often found in bacterial inva-
sins and hemagglutinins (Fig. 1A). Furthermore, the 89-C-
terminal-amino-acid sequence of UpaG contains a putative
translocator domain homologous to a C-terminal region of
YadA and other trimeric AT adhesins (Fig. 1B).
The amino acid sequence of the putative translocator unit of
UpaG contains three subdomains; L2 (amino acids 1690 to
1707), L1 (amino acids 1708 to 1724), and  (amino acids 1725
to 1778), all of which are highly conserved in members of the
trimeric AT adhesin family (37). Computer modeling of the
putative 3D structure of the last 107 amino acids of UpaG
generated and refined by energy minimization predicts an N-
terminal -helix of 37 amino acids (9–45) followed by four
antiparallel -sheets of 8, 9, 9, and 7 amino acids connected by
short turns (Fig. 1C). By analogy with other members of the
trimeric AT family, the trimerization of this region may pro-
duce a 12-strand -barrel that may form in the outer mem-
brane and facilitate the exposure of the N-terminal part of the
protein at the cell surface (Fig. 1C). The strong amino acid
sequence similarity of UpaG to other trimeric AT proteins, in
combination with these structural predictions, is compatible
with a model predicting a trimeric organization of the protein.
UpaG is located at the cell surface. Our structural predic-
tions of the C-terminal part of UpaG suggested that UpaG
might localize to the outer membrane. To test this tenet, we
raised a polyclonal rabbit antiserum against a region of UpaG
comprising amino acids 943 to 1224 of the N-terminal passen-
ger domain. Although we were able to detect very weak tran-
scription of upaG in CFT073 by quantitative reverse transcrip-
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tase real-time PCR (see Fig. S1 in the supplemental material),
immunodetection employing anti-UpaG antibodies failed to
detect the UpaG protein in CFT073 outer membrane prepa-
rations (Fig. 2A). To circumvent this expression problem, we
constructed a unique set of CFT073 UpaG overexpression
strains by inserting a chromosomally located, arabinose-induc-
ible (pBAD) or constitutive (PcL) promoter upstream of upaG
to generate the strain CFT073 RExBAD upaG or CFT073 PcL
upaG, respectively (15, 57). A band of the expected apparent
molecular mass (178 kDa) that reacted specifically with anti-
bodies directed against the N-terminal region of UpaG could
be detected in outer membrane preparations of the CFT073
RExBAD upaG cells in the presence of arabinose and from
CFT073 PcL upaG cells. In addition, bands with a higher
molecular mass that may represent UpaG multimers (includ-
ing trimers) were also observed (Fig. 2A). To demonstrate the
surface localization of UpaG, we performed immunofluores-
cence microscopy (Fig. 2B). UpaG antiserum readily reacted
with intact cells expressing upaG, confirming that the N-termi-
nal region of UpaG was effectively translocated to the cell
FIG. 1. In silico analysis of the UpaG protein. (A) Schematic illustration of the domain organization of UpaG from E. coli CFT073, YadA from
Yersinia enterocolitica, and NhhA from Neisseria meningitidis. Indicated are the signal peptide (S.P.) and the localizations of the Hep-Hag and Him
domains (invasin and hemagglutinin domains). Alignments were generated using Clustal W. (B) Multiple-sequence alignment of the translocation
units from UpaG, YadA, and NhhA. Identical residues are indicated by shaded boxes, whereas conservative substitutions are indicated by
unshaded boxes. The L2, L1, and  subdomains of UpaG are aligned with the corresponding regions from YadA and NhhA. (C) Computer model
of the putative 3D structure of UpaG. (a) Monomeric structure; (b) trimeric structure; (c) upper view. The different subregions are in green (),
red (L1), and yellow (L2).
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surface. No reaction was seen with CFT073 and CFT073
upaG cells. The surface location of UpaG was confirmed
using immunogold labeling and electron microscopy employ-
ing cell sections prepared from CFT073 PcL upaG (which
constitutively produces UpaG). In contrast, no evidence of
UpaG production was observed on the surfaces of CFT073
(Fig. 2C) or CFT073 upaG (data not shown) cells. Examina-
tion of the immunogold micrographs indicated that UpaG
could form structures extending approximately 100 nm from
the outer membrane (Fig. 2C); this is in agreement with our
estimates of the size of the exposed domain.
The C-terminal L1- region of UpaG is a functional trans-
porter domain. Trimeric AT proteins are characterized by
their short C-terminal translocator domain. To verify that the
C-terminal region of UpaG possessed translocation activity, we
assessed whether it could export a heterologous passenger
domain to the cell surface. We constructed a hybrid protein
combining the L2, L1, and  domains of the C-terminal region
FIG. 2. Surface localization of the UpaG passenger domain. (A) Western blot analysis of UpaG performed using outer membrane fractions
from CFT073, CFT073 upaG, CFT073 PcL upaG, and CFT073 RExBAD upaG in the presence () or absence () of 0.2% arabinose. Outer
membrane fractions were resolved by SDS-PAGE in the presence of 8 M urea. The monomeric form of UpaG is indicated (m), as are possible
dimers (d) and trimers (t). (B) Immunofluorescence assays of UpaG from CFT073, CFT073 upaG, CFT073 PcL upaG, and CFT073 RExBAD
upaG in the presence () or absence () of 0.2% arabinose. Overnight cultures were fixed and incubated with anti-UpaG serum, followed by
incubation with a secondary polyclonal goat anti-rabbit serum coupled to Alexa 488 and DAPI. (C) Immunogold electron microscopy of cell
sections of CFT073 and CFT073 PcL upaG probed with anti-UpaG and then with gold-labeled anti-rabbit IgG. Anti-UpaG-labeled gold particles
were observed on the surface of CFT073 PcL upaG (but not CFT073) up to a distance of approximately 100 nm (arrows). One CFT073 cell and
two individual CFT073 PcL upaG cells are shown as representatives of the average labeling observed for cells in several fields of view.
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of UpaG and, in place of the UpaG passenger domain, the
leucine zipper domain of the c-Jun protein (Fig. 3A). c-Jun is
a eukaryotic transcriptional factor that has the ability to dimer-
ize through strong interactions imparted by its leucine zipper
fold (1, 2). It has been shown that the export of this c-Jun
leucine zipper domain to bacterial cell surfaces can promote,
by virtue of its dimerization properties, cell-cell interactions
and thus bacterial aggregation (74). Therefore, we hypothe-
sized that the production and export of the heterologous pas-
senger domain of the hybrid protein c-Jun-UpaGL2-L1- on the
surfaces of E. coli cells should confer novel autoaggregation
traits via c-Jun leucine zipper dimerization. The hybrid protein
was cloned into the pJun plasmid, in which the c-Jun leucine
zipper is fused to the PelB signal sequence and placed under
the control of the lac promoter (74) to generate the plasmid
pUpaGL2-L1-. The production of this hybrid protein was
demonstrated using an antibody directed against an E-tag
epitope located between the c-Jun leucine zipper and the
UpaG C-terminal potential translocator unit (Fig. 3B). To
test whether the translocator unit of UpaG could present
the leucine zipper sequence of c-Jun to the surfaces of
upaG-negative E. coli UT5600 cells, we monitored cell-to-
cell adhesion in an aggregation assay. In contrast to nonin-
duced cells which remained in suspension, E. coli cells in-
duced for the expression of UpaGL2-L1- aggregated
strongly and sedimented rapidly to the bottom of the tube
(Fig. 3C and D). These results suggest that the c-Jun leucine
zipper domain was, when fused to the UpaGL2-L1- domain,
effectively transported to the bacterial cell surface and could
facilitate cell-to-cell aggregation (74).
In order to identify the minimal C-terminal part of UpaG
able to efficiently export the heterologous passenger leucine
zipper of c-Jun, we also constructed hybrid proteins containing
the  domain of UpaG lacking the L2 subdomain or lacking
both the L2 and L1 subdomains (Fig. 1A). The hybrid proteins
were cloned into the pJun plasmid to generate the plasmids
pUpaGL1- and pUpaG, respectively (Fig. 3A). Immunode-
tection using anti E-tag antibodies performed on whole ex-
tracts of IPTG-induced E. coli cells transformed with the plas-
mids pUpaGL2-L1-, pUpaGL1-, and pUpaG allowed the
detection of the chimeric E-tag/c-Jun/UpaG proteins. All of
the hybrid proteins were produced in equivalent amounts and
migrated as monomeric polypeptides under denaturing condi-
tions (Fig. 3B). To compare the functional activities of these
hybrid proteins, we examined their ability to mediate bacterial
cell aggregation. Cells expressing pUpaGL2-L1- aggregated
more strongly and sedimented more rapidly to the bottom of
the tube than cells expressing UpaGL1-. Whereas the L2 do-
main was not fully required for transport of the passenger
domain, its presence appeared necessary for optimal transport,
indicating that it may contribute to the correct folding and
activity of the C-terminal transporter domain of UpaG. No
significant aggregation was observed from cells expressing
UpaG, suggesting that the L1 subdomain was absolutely re-
quired for efficient export of the N-terminal passenger domain.
Taken together, these results suggest that the UpaG C-termi-
nal region is a functional translocator domain and that the
UpaGL1- domain is necessary and sufficient to direct the
translocation of the hybrid passenger domain. These results,
combined with our immunoelectron microscopy experiments,
confirm that UpaG is located in the outer membrane.
Expression of UpaG leads to increased aggregation and
biofilm formation. To investigate the functional role of UpaG
at the bacterial cell surface, we tested whether the expression
of upaG could enhance biofilm formation by CFT073. As
shown in Fig. 4A, the expression of upaG in CFT073 RExBAD
upaG (following arabinose induction) and CFT073 PcL upaG
led to a significantly increased capacity to form a biofilm. In
contrast, the CFT073 upaG mutant strain did not display any
difference in biofilm growth from wild-type CFT073. To elim-
inate the possibility that this observation was limited to
CFT073, we expressed upaG in two other UPEC strains (U6
and U15) from our laboratory collection using the same con-
stitutive and inducible promoter system. As observed for the
CFT073 RExBAD upaG and CFT073 PcL upaG strains, the
expression of upaG dramatically increased biofilm formation
by both strains (Fig. 4A). In addition, the upaG gene was PCR
amplified from CFT073 and cloned as a transcriptional fusion
behind the tightly regulated araBAD promoter in the pBAD/
Myc-HisA expression vector. The resulting plasmid (pupaG)
was used to transform the upaG-negative E. coli K-12 strain
OS56 (62). Under inducing conditions, OS56(pupaG) pro-
duced a strong biofilm (data not shown).
The enhanced biofilm growth mediated by UpaG either
could be caused by direct adhesion or may occur as a result of
intercellular reactions that promote cell aggregation. To ex-
plore these possibilities, we examined the primary adherence
capacity of cells overexpressing UpaG to a glass surface within
a short (2-h) time span. The expression of upaG did not result
in an increase in the number of isolated adherent bacteria,
suggesting that UpaG production does not promote initial
cell-to-surface adhesion (data not shown). However, examina-
tion of the glass surface by phase-contrast microscopy revealed
the presence of large cell aggregates indicative of bacterial
clumping (data not shown). To further demonstrate the role of
UpaG in promoting cell-cell aggregation, we performed an
assay to examine the settling kinetics of CFT073, U6, and U15
in association with their respective derivative RExBAD upaG
and PcL upaG strains. As shown in Fig. 4B and C, while neither
CFT073, U6, nor U15 formed aggregates, the expression of
UpaG in all of these E. coli backgrounds resulted in strong cell
aggregation. Taken together, these results demonstrate that
the production of UpaG induces biofilm formation primarily
through the promotion of cell-cell aggregation.
UpaG also plays a role in bacterial adherence to epithelial
cells. The strong similarity between UpaG, NhhA, and YadA
(Fig. 1) suggested that UpaG might also play a role in adhesion
to epithelial cells. To test this, T24 bladder epithelial cell
monolayers were infected with CFT073, CFT073 PcL upaG, or
CFT073 upaG. The enumeration of cell-adherent bacteria
revealed that the CFT073 PcL upaG strain adhered to T24
cells 1.5-fold more efficiently than CFT073 or CFT073 upaG
(P  0.005) (Fig. 5A). In contrast, CFT073, CFT073 PcL
upaG, and CFT073 upaG did not display significant differ-
ences in adherence to HeLa cervical epithelial cells or BSC1
kidney epithelial cells (P was 0.265 or 0.0796, respectively)
(Fig. 5A). This suggested that UpaG may exhibit a specific
affinity for T24 cells. Consistent with this hypothesis, adher-
ence assays employing a coculture of mixed T24 cells express-
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FIG. 3. Surface localization of the c-Jun leucine zipper in a c-Jun–UpaG chimeric protein. (A) Schematic illustration of recombinant c-Jun–UpaG
proteins constructed in this study. The position of the PelB signal sequence (SS), the E-tag, the leucine zipper of c-Jun (noted as Jun), and the L2, L1,
and  subdomains are indicated, as is the lac promoter (plac). (B) Immunoblots of whole-cell protein extracts from induced cultures expressing the
different chimeric constructions. The blot was probed with anti-E-tag MAb. The UpaGL2-L1- protein migrated as a polypeptide of 23 kDa despite its
calculated mass of 19.8 kDa. The molecular masses of UpaG (14.6 kDa) and UpaGL1- (16.3 kDa) were as calculated. (C) Cell-cell aggregation driven
by the interaction of the surface-exposed leucine zipper dimerization domain in the different constructions in the presence (black) or absence (gray) of the inducer
IPTG. E. coli UT5600 was used as the control. IPTG-induced and uninduced cultures were left to stand without being shaken. Samples of 100 
l were taken
from the top of the cultures (1 cm from the surface) at regular time intervals, and the OD600 was measured. The degree of aggregation is inversely proportional
to the turbidity. The OD600 just after the induction was taken as 100%. Data represent the means from three independent experiments. Standard deviations are
indicated by error bars. (D) Representative photographs of induced () and uninduced () E. coli cultures taken after 120 min without shaking.
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ing the red fluorescence protein and HeLa cells demonstrated
that the majority of CFT073 PcL upaG cells bound to T24 cells
(red cells) (Fig. 5B). This specificity for T24 cells was not
observed for CFT073 upaG. Taken together, these results
indicate that the production of UpaG by CFT073 specifically
enhances its capacity to adhere to T24 bladder epithelial cells.
UpaG binds to the ECM proteins laminin and fibronectin.
A property of many trimeric AT proteins is their ability to
mediate adherence to a variety of substrates, including ECM
components. The ability of UpaG to mediate binding to se-
lected human ECM components was examined by in vitro
binding assays. CFT073, CFT073 upaG, CFT073 PcL upaG,
and CFT073 RExBAD upaG cells were added to wells of
96-well plates coated with purified plasma laminin, heparan,
fibronectin, and collagens I, III, and IV. BSA was used as
negative control in the assay. Cell adherence to ECM proteins
was detected with a polyclonal serum raised against E. coli and
quantified by ELISA. As shown in Fig. 6, CFT073 PcL upaG
and arabinose-induced CFT073 RExBAD upaG cells adhered
strongly to fibronectin and laminin. This binding was not type
1 fimbria dependent, as the same adhesion profile was observed
in the presence of 0.1 M -D-mannose (data not shown). No
adherence to these ECM proteins was observed for CFT073 or
CFT073 upaG. These results support our previous findings in-
dicating the cell surface location of UpaG and demonstrate that
UpaG can promote significant adherence of E. coli to fibronectin
FIG. 4. Biofilm formation and aggregation phenotypes. (A) Static biofilm formation in polystyrene microtiter plates by CFT073, UPEC-6, and
UPEC-15 (and their upaG derivatives) in the presence () or absence () of 0.2% arabinose, where indicated. Biofilm growth was quantified by
the solubilization of crystal violet-stained cells with ethanol-acetone and the determination of the absorbance at 570 nm. WT, wild type.
(B) Autoaggregation assay demonstrating the settling profiles from liquid suspensions of CFT073/UPEC-6/UPEC-15 (black circles), CFT073/
UPEC-6/UPEC-15 PcL upaG derivatives (gray circles), and CFT073/UPEC-6/UPEC-15 RExBAD upaG derivatives in the presence (gray triangles)
or absence (black triangles) of 0.2% arabinose. Cells were diluted to an OD600 of 2.5 in a 3.0-ml volume. One-hundred-microliter samples were
taken from the top of the cultures (1 cm from the surface) at regular time intervals, and the OD600 was measured. (C) Photographs of E. coli
cultures taken after 24 h without shaking.
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and laminin (P  0.001). Interestingly, immunodetection experi-
ments using antifibronectin antibodies showed that T24 cells con-
tained at least a 10-fold-higher quantity of fibronectin than HeLa
cells (Fig. S2). The capacity of UpaG to bind to fibronectin could
therefore explain the preferential adhesion of CFT073 PcL upaG
to T24 bladder epithelial cells.
Prevalence of upaG in UPEC. The widespread occurrence of
trimeric AT adhesins in gram-negative pathogens prompted us
to investigate the prevalence of upaG in a well-characterized
collection of 191 UPEC and commensal E. coli isolates of
human and animal origins (45). For this purpose, we employed
primers designed to amplify the region encompassing nucleo-
tides 943 to 1224 of upaG. We found that a base pair product
of the correct size was amplified from 40 of the 191 strains
tested (21%). Further analysis revealed that 93% (37 of these
40 upaG-positive strains) of the PCR-positive strains belonged
to the E. coli B2 and D phylogenetic groups, both of which are
experimentally and epidemiologically associated with extrain-
testinal infections (9, 10, 48), and that 7% (3 of the 40 upaG-
positive strains) belonged to the A or B1 phylogenetic group.
In total, the percentage of B2 and D strains positive for upaG
was 35%, compared to less than 4% for the remaining phylo-
genetic groups. These results are in good agreement with a
recent report that examined the prevalence of upaG in a small
selection of ExPEC strains (17) and suggest that upaG is fre-
quently associated with ExPEC.
Evaluation of the role of UpaG in the colonization of the
mouse urinary tract. To study the role of UpaG in virulence,
we examined the ability of CFT073, CFT073 upaG, and
CFT073 PcL upaG to survive in the mouse urinary tract. There
was no significant difference in the abilities of the three strains
to colonize the C57BL/6 mouse bladder on day 1 (short term)
or day 5 (longer term) following infection (Fig. 7A). No colo-
nization of the kidneys was observed for any of the strains; this
is consistent with previous data from our laboratory using
C57BL/6 mice (71). To address the effect of upaG deletion or
constitutive expression on kidney colonization, we repeated
the same experiment using C3H/HeJ mice. C3H/HeJ mice are
defective in the Toll-like receptor 4 (TLR-4) protein, do not
respond to lipopolysaccharide, and are highly susceptible to E.
coli-induced pyelonephritis (44). At day 1 and day 5 following
the infection of C3H/HeJ mice, there was no significant differ-
ence in the abilities of the three strains to colonize the bladder
or kidneys (Fig. 7B).
DISCUSSION
AT proteins represent one of the major families of secreted
proteins in gram-negative bacteria. Recently, a specialized
class of AT adhesins that adopt a trimeric protein conforma-
tion and remain anchored to the cell surface were described
(12, 43, 47, 77). In this study, we characterized UpaG, a new
functional member of the trimeric AT proteins. UpaG is the
first trimeric AT protein to be characterized in detail from E.
coli, and its prevalence is strongly associated with E. coli strains
from the B2 or D clonal group.
One of the most conserved features of the trimeric AT
family is the translocator unit. Studies of the YadA and Hia
adhesins have revealed that the 70 and 76 C-terminal residues
of these proteins, respectively, are sufficient for the transloca-
tion of a heterologous passenger domain to the bacterial sur-
face (54). In the case of the NhhA trimeric AT protein from N.
meningitidis, the 72 C-terminal residues are sufficient for trim-
erization and localization of the N-terminal protein domain to
the bacterial surface (59). Here, we examined the region of
UpaG that could act as a functional translocation domain by
constructing a series of fusions to the c-Jun leucine zipper
hybrid domain. The 89 C-terminal amino acids of UpaG are
predicted to contain four -strands and a linker region with
two -helices (L1) and (L2); our data suggest that the last 71
amino acids of UpaG, corresponding to the L1- subdomain,
represent the translocator unit of UpaG. The reduced level of
aggregation observed in E. coli cells expressing a truncated
translocator unit in pUpaGL1- compared to that of a full-
length translocator unit in pUpaGL2-L1- could be due to a
FIG. 5. Adhesive properties of UpaG. (A) Adherence of CFT073,
CFT073 upaG, and CFT073 PcL upaG strains to T24, HeLa, and
BSC1 epithelial cells. Values correspond to the means  standard
deviations from three independent experiments (, denotes a P of
0.01). WT, wild type. (B) Adherence of CFT073 upaG and CFT073
PcL upaG cells to a mixed monolayer of T24 cells expressing the red
fluorescence protein (red cells) and HeLa cells. Actin was labeled by
phalloidin Alexa 647 (in blue), revealing all eukaryotic cells. Bacteria
were observed using phase-contrast microscopy and colored green
using Adobe Illustrator CS software. CFT073 PcL upaG adhered in
significantly greater numbers to T24 bladder epithelial cells than to
HeLa epithelial cells (left panel). In contrast, CFT073 upaG showed
no difference in adherence to T24 bladder epithelial cells and HeLa
epithelial cells (right panel).
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slightly reduced efficiency of translocation. Alternatively, we
cannot exclude the possibility that the reduced size of the
linker between the  domain and the passenger domain might
result in the decreased stability of the protein and therefore
the reduced interaction between the leucine zipper domains of
c-Jun.
We recently characterized the Ag43a and Ag43b AT ad-
hesins from UPEC CFT073 and demonstrated that the Ag43a
variant contributes to long-term persistence in the urinary
bladder (71). This study identified the existence of pathogenic-
ity-adapted variants of Ag43 with distinct virulence-related
functions. Ag43-mediated aggregation and biofilm formation
were not observed in CFT073 when the Ag43a and Ag43b
proteins were constitutively produced, suggesting that addi-
tional structures at the cell surface may mask their function.
Unlike with these observations, the expression of UpaG in
CFT073 produced a strong aggregation phenotype and pro-
moted significant biofilm growth. We attribute these different
phenotypes to the size difference between Ag43 and UpaG.
Whereas the passenger domain of Ag43 comprises 498 amino
acids and is predicted to extend approximately 10 nm from the
bacterial outer membrane (31), 3D modeling suggested that
the passenger domain of UpaG that is exposed to the surface
comprises around 1,700 amino acids, and we estimate from
immunogold EM images that it is approximately 100 nm in
size. This is consistent with size predictions for the passenger
domain of other members of the trimeric AT family. For ex-
ample, the size of the exposed domain of YadA, a 455-amino-
acid protein, was measured at about 23 nm (27), whereas the
exposed domain of BadA, a giant 3,082-amino-acid protein,
was estimated to be about 300 nm (52).
While conventional AT proteins have diverse effector func-
tions, including cytotoxicity, lipase or protease activity, and
adhesin properties, it appears that all trimeric AT proteins
identified so far display an adhesive activity mediating bacterial
interactions with either host cells or ECM proteins (4, 12, 13,
55, 59, 66). Consistent with these data, the results reported
here demonstrate that UpaG mediates the adherence of E. coli
to T24 bladder epithelial cells. In addition, we also observed
that the expression of UpaG mediated cell-to-cell aggregation
and biofilm formation by E. coli on abiotic surfaces. While we
have no information with regard to the structural domains of
UpaG responsible for these different functions, binding to eu-
karyotic cells/ECM proteins might be due to Him and Hep-
Hag motifs found in the passenger domain of the protein.
These domains are known to contribute to the binding activity
of other proteins from the invasin/hemagglutinin family. Crys-
tal structure determinations from other trimeric AT proteins
have demonstrated that in each case the passenger domain has
threefold symmetry and three identical faces. This structure
provides the potential for three binding pockets to adhere with
strong affinity to receptor targets (14). Moreover, many Hia-
like and YadA-like AT proteins possess predicted coiled-
coiled motifs, raising the possibility of multimerization of the
passenger domain. This may provide one explanation for the
ability of UpaG to promote bacterial cell aggregation (14).
Adherence to human ECM proteins is an important aspect
of host colonization for many bacterial pathogens, including N.
meningitidis, H. influenzae, Helicobacter pylori, Streptococcus
pyogenes, and Staphylococcus aureus (18, 19, 38, 49). The tri-
meric YadA, UspA2, and NhhA AT proteins are all associated
with high-affinity bacterial binding to ECM proteins (41, 59,
FIG. 6. Adherence to ECM proteins. Adherence of CFT073, CFT073 upaG, CFT073 PcL upaG, and CFT073 RExBAD upaG in the presence
of 0.2% of arabinose () or glucose () to heparan, laminin, fibronectin, and collagens I, II, and IV. Cells that adhered to ECM proteins were
detected with a polyclonal serum raised against E. coli and quantified by ELISA. Data are means ( standard deviations) from two independent
experiments. WT, wild type.
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69). Our data revealed that UpaG mediates the binding of E.
coli to laminin and fibronectin and that this binding is inde-
pendent of type 1 fimbriae. The UpaG-specific adhesion to T24
bladder cells could be explained by the differential expression
of eukaryotic cell surface ligands. Indeed, we observed that
T24 bladder cells possess a higher level of fibronectin than
HeLa cells. Since ECM proteins become exposed following
epithelial cell damage, adhesins such as UpaG that mediate
binding to fibronectin and laminin may contribute to coloni-
zation by promoting adherence at such sites. However, we note
that this does not exclude the possibility of the existence of a
specific host receptor for UpaG. Interestingly, the YadA pro-
tein has been shown to mediate tissue-specific colonization by
Yersinia pseudotuberculosis (28), implying a possible differential
affinity of this protein for different cellular types, as was ob-
served for UpaG.
Based on the E. coli genome sequences available within the
NCBI database, the chromosomal location of upaG appears to
be conserved; upaG is located upstream of lldP, a gene encod-
ing an L-lactate permease. Interestingly, the presence of upaG
orthologs seems to be restricted to some closely related enter-
obacteriaceae, including E. coli, Shigella species, and Salmo-
nella species (5, 35).
Orthologs of upaG are absent from genera such as Yersinia
and other proteobacteria from the gamma subdivision. This
suggests either that upaG acquisition occurred after the sepa-
ration of E. coli and related enterobacteria or that there is a
correlation between UpaG and the environment encountered
by enterobacteria, such as in the animal gut. However, the
existence of paralog proteins containing typical Hep-Hag/Him
and YadA-like motifs in various bacterial species suggests that
this type of adhesin has been acquired independently to fulfill
similar functions. E. coli strains fall into four main phyloge-
netic groups (A, B1, B2, and D) (26). Strains associated with
invasive extraintestinal clinical syndromes, such as bacteremia,
pyelonephritis, prostatitis, and meningitis, belong mainly to
group B2 and to a lesser extent to group D. In contrast, most
commensal strains and other strains associated with less inva-
sive syndromes, such as cystitis, generally belong to group A
(48). Our epidemiological data provide molecular evidence to
suggest that upaG is significantly more frequently associated
with E. coli strains from phylogenetic groups B2 and D. These
data are consistent with a previous report that demonstrated
an association between upaG and ExPEC strains that cause
bacteremia as well as the absence of upaG in certain E. coli
strains, such as members of the K-12 lineage (17).
The apparent lack of production of UpaG in E. coli CFT073
in vitro correlates with a previous report that examined UpaG
production in the neonatal meningitis E. coli strain S26 (17).
Those authors demonstrated that immunization of mice with
UpaG provided significant protective immunity against a lethal
intraperitoneal challenge with E. coli S26. Although UpaG
expression could not be detected during the laboratory growth
of E. coli S26, pooled human sera collected from patients
FIG. 7. Role of UpaG in virulence. (A) Persistence of CFT073, CFT073 upaG, and CFT073 PcL upaG in the bladders of C57BL/6 mice
following intraurethral challenge. At days 1 and 5 following infection, all three strains were recovered in equivalent numbers. (B) Persistence of
CFT073, CFT073 upaG, and CFT073 PcL upaG in the bladders and kidneys of C3H/HeJ mice following intraurethral challenge. At day 1 and
day 5 following infection, there was no significant difference in the abilities of the three strains to colonize the bladder or kidneys.
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suffering from bacteremia due to ExPEC infection reacted
positively with UpaG in immunoblot experiments, suggesting
that UpaG is produced during bacteremic infection and can
induce a host antibody response. We detected weak transcrip-
tion of upaG by quantitative reverse transcription-PCR follow-
ing the in vitro growth of CFT073. However, we were unable to
detect the expression of the corresponding protein by Western
blotting using UpaG-specific antiserum on outer membrane
preparations of CFT073 grown under the same conditions.
Furthermore, the upaG mutant of CFT073 showed no statis-
tically significant difference from the parent strain in its ability
to colonize the mouse urinary tract in both C57BL/6 and C3H/
HeJ mouse infection models. The lack of expression of UpaG
by CFT073 appears to be consistent with other studies, since
UpaG was not detected among outer membrane proteins pre-
pared from CFT073 following colonization of the mouse blad-
der (65) or after CFT073 infection of the mouse peritoneal
cavity (51). However, the fact that passive immunization of
mice with UpaG could protect them from a lethal systemic
challenge, combined with the observation that an antibody
response to UpaG can be detected in patients with bacteremia,
suggests that the expression of upaG may be enhanced during
infection.
The CFT073 PcL upaG strain was constructed to examine
the effect of UpaG constitutive expression in a defined UPEC
background. CFT073 PcL upaG aggregated strongly, formed
an excellent biofilm and adhered to laminin, fibronectin, and
T24 bladder epithelial cells. The direct association between
UpaG expression and these phenotypes was confirmed by the
construction and examination of two additional UpaG-produc-
ing strains (U6 and U15). When CFT073 PcL upaG was ex-
amined in the C57BL/6 mouse UTI model, no significant dif-
ference was observed in the levels of colonization of the
bladder. The same result was obtained using the C3H/HeJ
mouse infection model, although there was a trend in the data
to suggest that CFT073 PcL upaG colonized the bladder and
kidney less efficiently that the parent CFT073 strain. We spec-
ulate that this may be due to the forced expression of UpaG,
which may interfere with the functions of other surface ad-
hesins, as has been described previously (6, 23, 60, 62, 71, 72).
While UpaG has recently been found to be a promising
ExPEC vaccine candidate (17), an understanding of the func-
tions associated with UpaG expression as well as an investiga-
tion of its regulation under in vitro and in vivo conditions is
required to gain a better understanding of the arsenal of ad-
hesins used by E. coli to colonize the urinary tract and other
human sites.
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